Legends leave Legacys~
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Maybe MCM can stack a sign on top too!
http://medicalcannabismanagement.com/
"The Company plans to manage several medical cannabis dispensaries throughout California and receive a percentage of sales for the services provided. It is estimated that a dispensary generates an average of $1,000,000 per year."
~Might as well stack a BionicCig poster in there as well...
Kinda funny to see that RFMK is a sponser as well?? You think they'll have a tent :)~
Awsome!!
""I vape Albuterol Sulfate. Don't put that other stuff in your lungs.""
"FDA issued a Public Health Advisory notifying the medical community of two recent hospital outbreaks of lower respiratory tract colonization and infection with Burkholderia cepacia attributed to contaminated multi-dose bottles of albuterol sulfate. In most cases, colonization or infection occurred in the ICU setting, often in patients receiving mechanical ventilation. The advisory reminds healthcare professionals of measures that may be important in reducing the risk of contamination and subsequent outbreaks of infections. (The link below opens a new browser window with the advisory notice.)"
http://www.drugs.com/fda/albuterol-sulfate-solution-inhalation-3.html
"Seek medical attention right away if any of these SEVERE side effects occur when using Albuterol:"
"Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue); chest pain; ear pain; fast or irregular heartbeat; new or worsened trouble breathing; pounding in the chest; red, swollen, blistered, or peeling skin; severe headache or dizziness; unusual hoarseness; wheezing."
Wheres the pump?? Its been bleading for months!?!?
Cannabis Science Published on HIV Haven.com “Cannabinoid Research Shows Promise for HIV TAT Inhibition” Authored by Dr. R...
Cannabis Science (CBIS), a pioneering U.S. Biotech Company developing pharmaceutical products for global public health challenges is pleased to announce the Company has published an article on HIV Haven (www.hivhaven.com), a dynamic international HIV community website. The article entitled “Cannabinoid Research Shows Promise for HIV TAT Inhibition” is written by Dr. Robert Melamede, Ph.D., President of Cannabis Science Inc., and Dr. David Miller, Ph.D., an AIDS treatment activist.
The article focuses on recent research, which demonstrated the ability of Phytocannabinoids to inhibit HIV TAT a vital function of HIV, as well as Cannabis Sciences’ recently launched Cannabinoid inhibitory HIV TAT platform called CS-TATI-1.
Dr. Robert Melamede, Ph.D., President & CEO of Cannabis Science stated, “We are very happy to present this article on HIV Haven that demonstrates the promise of cannabinoid research in HIV. Community support in influencing important drug development is exemplified no where better than amongst AIDS treatment activists and the global HIV community. We expect to create further interest at the 19th International AIDS Conference (AIDS 2012) this July at our presentation which will take place at the World AIDS Institute AIDS 2012 Reunion Treatment Horizon Satellite symposium series.”
“HIV Haven, like other HIV media outlets, is very aware of the crisis in HIV drug resistance currently facing people with HIV worldwide. This article will hopefully stimulate further interest in this promising arena leading to the further investigation of the relationship between phytocannabinoids and TAT. Cannabis Science is currently the only company looking at the commercial development of a Phytocannabinoid based TAT inhibitor and we hope to understand more about the promise of CS-TATI-1 as it matures through preclinical development,” stated Jeannie Wraight, Editor-in-Chief of HIV Haven.
About CS-TATI-1
Data published in March by researchers at the Mount Sinai School of Medicine found that cannabinoids inhibit TAT induced migration to TAT via cannabinoid 2 receptors (CB2). Funding for the Mount Sinai study was provided by a National Institutes of Health (NIH) Clinical and Translational Science Award Grant. Cannabis Science’s research of CS-TATI-1 will be targeted to newly diagnosed patients infected with drug resistant virus, treatment experienced patients with drug-resistant HIV strains, and those intolerant of currently available therapies. Cannabis Science will be pursuing a wide range of NIH based Federal Research Programs such as RO1’s, PO1’s and SBIRS which exist to support preclinical development of target validation and proof of concept studies. These studies will be implemented through collaborations with leading scientific institutions. Cannabis Science will also be pursuing other clinical research collaborations including the AIDS Clinical Trials Groups (ACTG), the Canadian AIDS Trial Network (CATN) and the European AIDS Trial Network (EATN).
About HIV
HIV’s ability to mutate and reproduce itself even in the presence of antiretroviral drugs, has led to a growing rate of drug resistance. Increasing drug resistance is severely limiting treatment options for HIV patients around the world, increasing direct and indirect health costs, furthering the spread of drug resistant strains of HIV and is creating a pressing need to develop new HIV drugs.
The U.S. government invests billions of dollars a year in HIV/AIDS research, treatment and care through a variety of programs. The Ryan White CARE Act, which funds the treatment and care of people living with HIV in the U.S., totals $2.3 billion a year. Among its many other contributions to fighting HIV/AIDS globally, the U.S. provides $22.8 million annually to The U.S. Military HIV Research Program and approximately $1 billion per year to The Global Fund to Fight AIDS, Tuberculosis and Malaria. Pharmaceutical sales to treat HIV equal US $10.6 billion annually. Treatment cost per patient in the U.S. for HIV antivirals alone is approximately US $15,000 a year.
About HIV Haven (www.hivhaven.com)
HIV Haven is an international website that caters to people infected and affected by HIV and those working in the HIV field. HIV Haven provides its readers with daily HIV news in the U.S. and across the globe, articles on various HIV topics, blogs written by a multitude of people including Timothy Brown, the only man cured of HIV. HIV haven is an official sponsor of AIDS2012 Reunion (www.aids2012reunion.com) and the official host of AIDS2012 Reunion news.
About Cannabis Science, Inc.
Cannabis Science, Inc. is at the forefront of cannabinoid research and development for unmet medical needs. The Company works with leading experts such as Dr. Roscoe M. Moore Jr., DVM, MPH, Ph.D., U.S. Assistant Surgeon General (Retired) for HIV drug development, medicinal characterization, and clinical research to develop, produce, and commercialize Phytocannabinoid-based pharmaceutical products.
As well, Cannabis Science is currently working with CBR International to develop a Pre-IND Application to the FDA that focuses on the use of CS-S/BCC-1 topical cannabis-based preparations for the treatment of basal and squamous cell carcinomas.
Forward Looking Statements
This Press Release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Act of 1934. A statement containing works such as "anticipate," "seek," intend," "believe," "plan," "estimate," "expect," "project," "plan," or similar phrases may be deemed "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Some or all of the events or results anticipated by these forward-looking statements may not occur. Factors that could cause or contribute to such differences include the future U.S. and global economies, the impact of competition, and the Company's reliance on existing regulations regarding the use and development of cannabis-based drugs. Cannabis Science, Inc. does not undertake any duty nor does it intend to update the results of these forward-looking statements.
Why does everyone here seem to think a PR stating that the shipment "has arrived" is going to spike the pps?? If that were the case a rally would have already begun...
~An update on the dilution would help, or how bout that chill Tom????
Okauchee Lake, he passed away several years ago.. Never really got a chance to meet him~
Funny you mention Ronald~ i actually live on same lake that the "Original Ronald Mcdonald" lived on!
Completly off topic, but your post caught my attention..
Well played newmed~
You werent kidding about your "dry humor"
Watch for the CANNAcig participating in the "BEST NEW PRODUCT' category!
LOOK FOR OUR BOOTH
Our booth will feature hi-end production including top vapor sales reps, product models, talent, music, food, giveaways and an amazing surprise in store for attendees of the Cup which is sure to make an impact on everyone! This amazing set up will also be entered into the competition for "BEST BOOTH".
Well done burg! Great find~
Hmmm.... The "airs" ?
Care to elaborate?
Income Statement Get Income Statement for:
View: Annual Data | Quarterly Data All numbers in thousands
Period Ending Dec 30, 2011 Dec 30, 2010
Total Revenue 53 63
Cost of Revenue 1 -
Gross Profit 52 63
Operating Expenses
Research Development - -
Selling General and Administrative 1,246 4,063
Non Recurring - -
Others - -
Total Operating Expenses - -
Operating Income or Loss (1,193) (4,000)
Income from Continuing Operations
Total Other Income/Expenses Net 2 -
Earnings Before Interest And Taxes (1,191) (4,000)
Interest Expense - -
Income Before Tax (1,191) (4,000)
Income Tax Expense - -
Minority Interest - -
Net Income From Continuing Ops (1,191) (4,000)
Non-recurring Events
Discontinued Operations - -
Extraordinary Items - -
Effect Of Accounting Changes - -
Other Items - -
Net Income (1,191) (4,000)
Preferred Stock And Other Adjustments - -
Net Income Applicable To Common Shares (1,191) (4,000)
Cannabis Science Inc. (CBIS) Makes New Appointment to Advisory Board
Thursday, June 7th, 2012 | Filed under Internet,Technology | Posted by Adam Garcia
Cannabis Science Inc. (OTCBB: CBIS) stock is currently trading at $0.0730, up 21.67 percent from its previous close of $0.06. The stock today opened at $0.06 and touched the high of $0.0735 during the intraday trading. The stock’s lowest point during the day stood at $0.0601.
Cannabis Science announced that it has initiated the research program to discover the commercial aspects of its phytocannabinoid therapies for treating drug resistant HIV infection. The company said that it will also identify medicinal and structural biochemistry of its therapy. The research will be focused on the newly diagnosed patients suffering from HIV. The company also announced the appointment of Roscoe Moore to its Scientific Advisory Board. Dr. Moore has a Ph.D. in Epidemiology from the Johns Hopkins University.
Cannabis Science is a development stage company and is involved in the business of developing, producing and marketing pharma products. The company focuses on phytocannabinoid based therapies. Cannabis Science provides therapies to treat ailments like blood pressure, cancer and autism. Its therapies are also used to treat HIV infection and related problems. The company has a collaboration with Apothecary Genetics Investments LLC. Cannabis Science is based out of Colorado Springs in Colorado.
Are they 510 mods? It sounds like you either do or used to vape newmed~ ?
Wake up mods! The news from today should be stickied!!
The news shows POSITIVE GROWTH in the company~
"HHC has shown tremendous dedication to their patient base by choosing to test their full catalog of medicine with a reputable cannabis laboratory," adds BudGenius CEO, Angel Stanz. "While many dispensaries only test their top 5 to 8 strains, HHC has chosen to join the upper echelon of California dispensaries that demand the highest quality services for patient care. BudGenius is proud to have been selected by their discerning caregivers, and is honored to be assisting their actions in serving their local community."
"HHC has taken care to choose the highest quality medicine available, which consists of several farmers utilizing BudGenius services, as well as the world-famous High Times Cannabis Cup winning plant genetics by Ken Estes Mediceuticals, including popular strains Grand Daddy Purp™, Bay 11™, and Ken's Kush™. Grand Daddy Purp™ is well known for its pain relief qualities having been reported especially effective for arthritis and limb disabilities, while allowing patients to maintain focus and clarity."
http://kenwestes.com/ken-estes-biography/
More info on the studio~
http://www.bizjournals.com/tampabay/blog/2010/03/welcome_to_bubbaland.html
Probably the coolest studio out there~
Why? Lets hear it~
Care to disclose what "you heard"?
The funny part is Cheryl did EXACTLY what she intended to do! (((CREATE A BUZZ))))
Now everyone AND SEVERAL boards are discussing RFMK~ Good or bad, the attention she drew is very prevelent~
Vaporizers produces active vapor at temperatures ranging from 230°F - 420°F. while eliminating many toxins, examples such as - benzene, a known carcinogen, plus toluene and naphthalene. Carbon monoxide and smoke tars are both qualitatively reduced by the vaporizer. There is good reason to believe that the highly carcinogenic tars known as polycyclic aromatic hydrocarbons, which are thought to be a leading culprit in smoking-related cancers, are suppressed, since they normally form at much higher temperatures of combustion. Welcome to the world of vapor!
We are happy to announce Otherisde Health Management has entered the High Times Cannabis Cup 2012 in San Francisco, CA!
from Los Angeles, CA
Twitter for iPhone • 5/29/12 4:00 PM
Vaporizers produces active vapor at temperatures ranging from 230°F - 420°F. while eliminating many toxins, examples such as - benzene, a known carcinogen, plus toluene and naphthalene. Carbon monoxide and smoke tars are both qualitatively reduced by the vaporizer. There is good reason to believe that the highly carcinogenic tars known as polycyclic aromatic hydrocarbons, which are thought to be a leading culprit in smoking-related cancers, are suppressed, since they normally form at much higher temperatures of combustion. Welcome to the world of vapor!
Big week for VPER coming~
Viper Networks and Aequitas Energy Executives Reviewing Final Agreement Details Over Memorial Weekend
Press Release: Viper Networks, Inc. – Fri, May 25, 2012 9:05 PM EDT
http://finance.yahoo.com/news/viper-networks-aequitas-energy-executives-010502690.html
Viper Networks Reports Strong Progress on Multiple Projects and Acquisition Targets
Press Release: Viper Networks, Inc. – Wed, May 23, 2012 8:20 AM EDT
http://finance.yahoo.com/news/viper-networks-reports-strong-progress-122000314.html
Big week for VPER coming~
Viper Networks and Aequitas Energy Executives Reviewing Final Agreement Details Over Memorial Weekend
Press Release: Viper Networks, Inc. – Fri, May 25, 2012 9:05 PM EDT
http://finance.yahoo.com/news/viper-networks-aequitas-energy-executives-010502690.html
Viper Networks Reports Strong Progress on Multiple Projects and Acquisition Targets
Press Release: Viper Networks, Inc. – Wed, May 23, 2012 8:20 AM EDT
http://finance.yahoo.com/news/viper-networks-reports-strong-progress-122000314.html
oOoImagine the POP in the pps if the chill got dropped!~
Green Asset said it will target for purchase "profitable and successful companies that need more capital to reach their full potential."
"This creates a wonderful opportunity for entrepreneurs and smart investors to be on the ground floor of this exciting and groundbreaking industry," Shuman said. "There are great financial rewards coupled with a chance to be involved in a hot ticket business that is on the cutting edge."
http://www.tokeofthetown.com/2012/03/firm_dedicates_100_million_funding_facility_to_med.php